The inspection was conducted at its Goa, Verna manufacturing facility from 31 July 2023 to 4 August 2023. The inspection included comprehensive scrutiny of practices and procedures for reporting of adverse events of Marksans' marketed products.
The company will submit corrective and preventive action plan (CAPA) to the USFDA in the stipulated time frame.